These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33397519)

  • 1. The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Wei ZY; Qiao R; Chen J; Huang J; Wu H; Wang WJ; Yu H; Xu J; Wang C; Gu CH; Li HJ; Li M; Liu C; Yang J; Wang Y; Wang HY; Qian HY; Geng YJ
    Epidemiol Infect; 2021 Jan; 149():e4. PubMed ID: 33397519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in Patients Hospitalized with COVID-19 in Wuhan, China.
    Zhang Y; Sha T; Wu F; Hu H; Chen Z; Li H; Han J; Song W; Huang Q; Zeng Z
    Int Heart J; 2021 Mar; 62(2):337-343. PubMed ID: 33678794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.
    Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S
    BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.
    Tong L; Khani M; Lu Q; Taylor B; Osinski K; Luo J
    Obes Res Clin Pract; 2023; 17(1):47-57. PubMed ID: 36577559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study.
    Zhong L; Wu Y; Gao J; Zhang J; Xie Q; He H; Ji J; Liu Z; Wang C; Liu Z
    Ann Med; 2021 Dec; 53(1):770-776. PubMed ID: 34080499
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
    Liang WH; Guan WJ; Li CC; Li YM; Liang HR; Zhao Y; Liu XQ; Sang L; Chen RC; Tang CL; Wang T; Wang W; He QH; Chen ZS; Wong SS; Zanin M; Liu J; Xu X; Huang J; Li JF; Ou LM; Cheng B; Xiong S; Xie ZH; Ni ZY; Hu Y; Liu L; Shan H; Lei CL; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Cheng LL; Ye F; Li SY; Zheng JP; Zhang NF; Zhong NS; He JX
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32269086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities and clinical features related to severe outcomes among COVID-19 cases in Selangor, Malaysia.
    Hasani WSR; Ganapathy SS; Lin CZ; Rifin HM; Bahari MN; Ghazali MH; Lodz NA; Ramli MHT; Majid NLA; Ling MYJ; Yusoff MFM; Ahmad NA; Suleiman A; Yusoff AF; Balan V; Ngadiman S
    Western Pac Surveill Response J; 2021; 12(1):46-52. PubMed ID: 34094624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry.
    Bogojevic M; Bansal V; Pattan V; Singh R; Tekin A; Sharma M; La Nou AT; LeMahieu AM; Hanson AC; Schulte PJ; Deo N; Qamar S; Zec S; Valencia Morales DJ; Perkins N; Kaufman M; Denson JL; Melamed R; Banner-Goodspeed VM; Christie AB; Tarabichi Y; Heavner S; Kumar VK; Walkey AJ; Gajic O; Bhagra S; Kashyap R; Lal A; Domecq JP;
    Clin Endocrinol (Oxf); 2024 Jul; 101(1):85-93. PubMed ID: 35180316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics, comorbidities and risk factors for severe disease from the early SARS-CoV-2 infection cases in Queensland, Australia.
    Oats A; Phung H; Tudehope L; Sofija E
    Intern Med J; 2024 May; 54(5):786-794. PubMed ID: 37955361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
    Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
    Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China.
    Sun L; Shen L; Fan J; Gu F; Hu M; An Y; Zhou Q; Fan H; Bi J
    J Med Virol; 2020 Oct; 92(10):2055-2066. PubMed ID: 32369208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early risk factors of the exacerbation of coronavirus disease 2019 pneumonia.
    Wang CZ; Hu SL; Wang L; Li M; Li HT
    J Med Virol; 2020 Nov; 92(11):2593-2599. PubMed ID: 32470167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Study of Aging and Sex-Specific Risk Factors of COVID-19 with Hypertension in China.
    Wang J; Zhang Y; Li K; Du K; Huang X; Zhou Z; Ma Y; Guo S; Hou Y; Li Q; Xu H; Huang J; Huang Q; Na H; Wang J; Wang X; Xiao Y; Zhu J; Chen H; Liu Z; Wang M; Zhang L; Wang W; Wan H
    Cardiovasc Ther; 2022; 2022():5978314. PubMed ID: 35846735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
    Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group
    Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study.
    Xiang HX; Fei J; Xiang Y; Xu Z; Zheng L; Li XY; Fu L; Zhao H
    BMC Infect Dis; 2021 Feb; 21(1):158. PubMed ID: 33557785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study.
    Bauer AZ; Gore R; Sama SR; Rosiello R; Garber L; Sundaresan D; McDonald A; Arruda P; Kriebel D
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):21-27. PubMed ID: 33220171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization.
    Russo V; Piccinocchi G; Mandaliti V; Annunziata S; Cimmino G; Attena E; Moio N; Di Micco P; Severino S; Trotta R; Del Guercio M
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33375676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19.
    McFarlane E; Linschoten M; Asselbergs FW; Lacy PS; Jedrzejewski D; Williams B;
    Hypertens Res; 2022 May; 45(5):834-845. PubMed ID: 35352027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.